logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Junji Uchida

department of urology
H指数:40
被引数:8,215

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic intravenous dexamethasone is associated with reduced cutaneous toxicity during first-line enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma: a multicenter prospective cohort study

预防性静脉注射地塞米松与局部晚期或转移性尿路上皮癌一线恩沃利单抗联合帕博利珠单抗治疗期间皮肤毒性降低相关：一项多中心前瞻性队列研究

International Journal of Clinical Oncology
IF2.8
2026-09-020
PRE
Rikiya Taoka; Keita Tamura; Takuya Tsujino; Keita Kobayashi; Makito Miyake; Kohei Ogawa; Yutaro Sasaki; Shuichi Tatarano; Satoshi Katayama; Minoru Kato; Hideo Fukuhara; Yohei Abe; Yuki Oda; Ryoei Minato; Ryu Shigehisa; Teruo Inamoto; Haruhito Azuma; Koji Shiraishi; Kiyohide Fujimoto; Koichiro Wada; Junya Furukawa; Hideki Enokida; Motoo Araki; Junji Uchida; Keiji Inoue; Mikio Sugimoto
Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer

非小细胞肺癌患者接受一线免疫检查点抑制剂治疗期间，预存间质性肺病对肺炎及生存的影响

European Journal of Cancer
IF7.1
2026-06-210
OA
Kinnosuke Matsumoto; Yuji Yamamoto; Takayuki Shiroyama; Tomoki Kuge; Akito Miyazaki; Kiyohide Komuta; Motohiro Tamiya; Kazumi Nishino; Akihiro Tsukaguchi; Akihiro Tamiya; Yasuhiro Mihashi; Junji Uchida; Masahide Mori; Keijiro Yamauchi; Hidekazu Suzuki; Yuhei Kinehara; Koki Moritomo; Nao Shoshihara; Hirotomo Machiyama; Kensuke Kanaoka
Robot-assisted laparoscopic radical nephrectomy for renal cell carcinoma with direct colon invasion and concomitant inferior vena cava tumor thrombus: A case report

机器人辅助腹腔镜根治性肾切除术治疗伴有直接结肠侵犯及合并下腔静脉瘤栓的肾细胞癌：病例报告

UROLOGY CASE REPORTS
IF0.4
2025-09-010
OAAI
Hamada, Kosuke; Yamasaki, Takeshi; Masaki, Nawa; Yamamoto, Shoma; Matsue, Taisuke; Yukimatsu, Nao; Otoshi, Taiyo; Kato, Minoru; Kuratsukuri, Katsuyuki; Uchida, Junji
Osimertinib as First-Line Treatment for Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer in a Real-World Setting: Updated Overall Survival Data (OSI-FACT-OS)

奥希替尼作为EGFR突变阳性晚期非小细胞肺癌患者一线治疗的真实世界研究：总体生存数据更新（OSI-FACT-OS）

Clinical Lung Cancer
IF3.3
2025-06-100
PRE
Yoshihiko Sakata; Go Saito; Shinya Sakata; Teppei Yamaguchi; Motohiro Tamiya; Hidekazu Suzuki; Ryota Shibaki; Asuka Okada; Toshihide Yokoyama; Hirotaka Matsumoto; Taiichiro Otsuki; Yuki Sato; Junji Uchida; Yoko Tsukita; Megumi Inaba; Hideki Ikeda; Daisuke Arai; Hirotaka Maruyama; Satoshi Hara; Shinsuke Tsumura; Jun Morinaga; Takuro Sakagami
Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study

广泛期小细胞肺癌根据关键临床试验入组标准进行的化疗免疫疗法长期预后：一项前瞻性队列研究的3年结果

LUNG CANCER
IF4.4
2025-01-010
PRE
Sugisaka, Jun; Fujimoto, Daichi; Tamiya, Motohiro; Hata, Akito; Matsumoto, Hirotaka; Yokoyama, Toshihide; Taniguchi, Yoshihiko; Uchida, Junji; Sato, Yuki; Kijima, Takashi; Tanaka, Hisashi; Furuya, Naoki; Masuda, Takeshi; Sakata, Yoshihiko; Miyauchi, Eisaku; Saito, Go; Miura, Satoru; Yamaguchi, Teppei; Daga, Haruko; Sakata, Shinya; Yamamoto, Nobuyuki; Akamatsu, Hiroaki
Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)

局部晚期非小细胞肺癌放化疗和巩固Durvalumab治疗后进展后后续化疗的真实世界结果: 来自CRIMSON研究的探索性分析 (HOPE-005)

CLINICAL LUNG CANCER
IF3.3
2024-11-012
PRE
Kawachi, Hayato; Tamiya, Motohiro; Oya, Yuko; Saito, Go; Taniguchi, Yoshihiko; Matsumoto, Hirotaka; Sato, Yuki; Otsuki, Taiichiro; Suzuki, Hidekazu; Fukuda, Yasushi; Tanaka, Satoshi; Tsukita, Yoko; Uchida, Junji; Sakata, Yoshihiko; Nakatani, Yuki; Shibaki, Ryota; Arai, Daisuke; Okada, Asuka; Hara, Satoshi; Takayama, Koichi; Nishino, Kazumi
CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy
SCIENTIFIC REPORTS
IF3.9
2024-08-020
OAAI
Yaga, Moto; Hasegawa, Kana; Ikeda, Shunya; Matsubara, Miwa; Hiroshima, Takashi; Kimura, Toru; Shirai, Yuya; Tansri, Wibowo; Uehara, Hirofumi; Tachikawa, Mana; Okairi, Yuzuru; Sone, Masayuki; Mori, Hiromi; Kogue, Yosuke; Akamine, Hiroki; Okuzaki, Daisuke; Kawagishi, Kotaro; Kawanaka, Satoshi; Yamato, Hiroyuki; Takeuchi, Yukiyasu; Okura, Eiji; Kanzaki, Ryu; Okami, Jiro; Nakamichi, Itsuko; Nakane, Shigeru; Kobayashi, Aki; Iwazawa, Takashi; Tokunaga, Toshiteru; Yokouchi, Hideoki; Yano, Yukihiro; Uchida, Junji; Mori, Masahide; Komuta, Kiyoshi; Tachi, Tetsuro; Kuroda, Hideki; Kijima, Noriyuki; Kishima, Haruhiko; Ichii, Michiko; Futami, Shinji; Naito, Yujiro; Shiroyama, Takayuki; Miyake, Kotaro; Koyama, Shohei; Hirata, Haruhiko; Takeda, Yoshito; Funaki, Soichiro; Shintani, Yasushi; Kumanogoh, Atsushi; Hosen, Naoki

研究方向

暂未获取到该数据
T
Tatsuya Nakatani
H 指数:51论文数:818被引数:1.2万
K
Kazuya Kabei
H 指数:12论文数:71被引数:433
T
Toshihide Naganuma
H 指数:23论文数:170被引数:1,736
T
Tomoaki Iwai
H 指数:18论文数:169被引数:1,079
M
Motohiro Tamiya
H 指数:32论文数:372被引数:3,527
T
Toru Kumagai
H 指数:42论文数:253被引数:6,724
A
Akihiro Tamiya
H 指数:29论文数:226被引数:2,838
F
Fumio Imamura
H 指数:55论文数:400被引数:2.2万
S
Shunji Nishide
H 指数:10论文数:58被引数:337
D
Daichi Fujimoto
H 指数:35论文数:243被引数:3,929